Last updated: August 1, 2025
Introduction
WIPO Patent Application WO2011087765, titled "Method for Treatment or Prevention of Cardio- and Cerebrovascular Diseases," exemplifies a strategic approach toward medical innovation, primarily focused on therapeutic applications related to cardiovascular and cerebrovascular conditions. As a WIPO publication, this patent application signals an intent to secure international patent rights before entering specific national markets, offering a foundation to assess scope, claims, and the broader patent landscape.
Scope of WO2011087765
The scope of WO2011087765 centers on novel methods for treating or preventing cardiovascular and cerebrovascular diseases using specific pharmaceutical compositions and therapeutic regimens. The applicant proposes a detailed approach involving particular agents, dosages, and treatment schedules, aiming to address deficiencies in existing therapies.
Key aspects of the scope include:
- Therapeutic Methods: Focused on administering certain pharmaceutical agents, potentially including small molecules, peptides, or biologics, designed to modulate pathways implicated in cardiovascular health.
- Target Indications: Encompasses conditions such as ischemic heart disease, stroke, hypertension, and other related disorders.
- Treatment Regimens: Emphasizes particular dosing strategies and combinations, possibly including prophylactic and therapeutic applications.
The application’s scope is thus broad enough to cover various agents and their use in preventing or managing specific vascular diseases, while still maintaining a focus on method-based claims rather than product claims alone.
Claims Analysis
The claims, forming the core legal definition of the invention, are structured to delineate the precise boundaries of protection. Although the specific language of WO2011087765's claims may vary, based on typical applications of this nature, they likely include:
-
Method Claims: Covering specific treatment protocols involving the administration of at least one active pharmaceutical agent to a patient suffering from or at risk of cardio- or cerebrovascular diseases. These could specify dosing regimes, timing, or combination therapies.
-
Composition Claims: Potentially claiming pharmaceutical compositions comprising particular active agents and carriers, designed for the treatment of the targeted diseases.
-
Use Claims: Covering the use of specific compounds or combinations thereof for the manufacture of a medicament for treating or preventing these diseases.
Critical analysis of claims:
- The method claims appear to be directed toward novel treatment regimens, potentially providing a strategic advantage if they include unique dosing or combination features.
- Composition claims may be narrower, dependent on specific agents disclosed in the application.
- Use claims typically enhance the scope by protecting particular therapeutic uses, crucial for market exclusivity.
The breadth of these claims determines the scope of patent protection. Broader claims covering general indications or mechanisms can extend the patent's protectiveness across multiple therapeutic agents and methods, but they are also more susceptible to invalidation for lack of inventive step or novelty.
Patent Landscape and Strategic Positioning
1. Domestic and International Patent Environment
WO2011087765 exists within a dense patent landscape comprising numerous patents related to cardiovascular therapies. Key competitive areas include:
- Anti-inflammatory agents
- Endothelial function modulators
- Novel formulations of statins and other lipid-lowering drugs
- Biologics targeting vascular pathology
Given the broad scope of claims typical for such applications, there is potential overlap with existing patents from major pharmaceutical companies specializing in cardiovascular therapy (e.g., Pfizer, Novartis, Amgen). A comprehensive freedom-to-operate (FTO) analysis is necessary to identify potential conflicts.
2. Patent Families and Regional Coverage
Since WO2011087765 is a WIPO application, it serves as an international placeholder, with rights potentially pursued via national phase entries in jurisdictions like the US, EU, China, and Japan. The patent landscape will evolve as these national or regional applications mature.
- US and European Patents: May include counterparts with narrower or more specific claims.
- Chinese Patent Applications: Often form a critical part of strategic positioning, especially due to China's large market and emphasis on innovation protection.
3. Patent Trends and Innovation Hotspots
Emerging innovations related to vascular health generally focus on:
- Biologics and gene therapy approaches
- Nanotechnology-enabled drug delivery
- Personalized medicine strategies incorporating biomarkers
In this context, WO2011087765 appears aligned with the trend toward sophisticated, targeted vascular therapies, though the specific methods claimed will determine its differentiation.
4. Patent Challenges and Opportunities
Potential challenges include:
- Prior art rejections: The claims must be carefully drafted to avoid overlaps with existing patents on related therapeutic methods and compositions.
- Novelty and inventive step: The applicant must demonstrate that their treatment approach is sufficiently inventive over existing therapies.
Opportunities reside in optimizing claims to emphasize unique therapeutic combinations or novel mechanisms of action, thus strengthening enforceability.
Implications for Industry and Business Strategies
- Leverage global patent protection to establish a solid portfolio foothold in cardiovascular therapy markets.
- Align patent strategy with ongoing clinical development to maximize data supporting novelty and inventive step.
- Monitor competitor patent filings for similar therapeutic approaches, enabling preemptive positioning or licensing negotiations.
Key Takeaways
- WO2011087765 aims at broad therapeutic claims for treating cardiovascular and cerebrovascular diseases using specific regimens and compositions, positioning it within a competitive innovation domain.
- Claims are likely structured around method, composition, and use, offering multiple layers of patent protection but requiring vigilant drafting to ensure scope and defensibility.
- The patent landscape is crowded, with overlapping technologies involving biologics, targeted therapies, and drug delivery systems; strategic patenting and clear claim delineation are essential.
- International patent protections through PCT pathways are crucial for securing global rights, especially in major markets like the US, EU, and China.
- Ongoing developments in vascular therapeutics—including biologics, personalized medicine, and nanotech—present both challenges and opportunities for patent differentiation.
FAQs
1. What is the main therapeutic focus of WO2011087765?
It primarily targets methods for preventing or treating cardiovascular and cerebrovascular diseases, utilizing specific pharmaceutical treatment regimens.
2. How broad are the claims typically found in WIPO patent applications like WO2011087765?
They often include method claims, composition claims, and use claims, with scope depending on the specific language used and inventive step over prior art.
3. How does the patent landscape impact new drug development in cardiovascular therapies?
A densely populated patent landscape necessitates careful analysis to avoid infringement, while providing opportunities for licensing and cross-licensing of complementary technologies.
4. Why is international patent protection important for this kind of invention?
Cardiovascular drugs often target global markets; securing international patent rights ensures market exclusivity and potential licensing revenues.
5. What strategies can enhance the strength of patent claims for such therapeutic methods?
Focusing on novel mechanisms of action, specific dosing regimens, and unique combinations, supported by clinical data, can bolster patent claims’ scope and enforceability.
References
[1] World Intellectual Property Organization. Patent Cooperation Treaty. WO2011087765. Method for Treatment or Prevention of Cardio- and Cerebrovascular Diseases. 2011.
